ISPOR Europe 2026
Talk Access and Pricing track
One JCA, Many Decisions: Building an Evidence Strategy for Portability Across Europe
Mon, Nov 9, 2026 · 12:15–1:15 PM CET Hall F1, Level 0, Austria Center Vienna
About this session
Europe's Joint Clinical Assessment (JCA) framework is creating a more coordinated approach to clinical assessment, while access, reimbursement, and value decisions remain national. This symposium will examine evidence planning to address JCA requirements in the context of uncertainty as the PICOs scope is provided shortly before the dossier is due.
Speakers
-
Thermo Fisher Scientific
Speaker
